Abstract: The present disclosure discloses a high-voltage light string controller, including a first power supply module, a main control module, and a protection module. The first power supply module is suitable for being connected to a mains supply to supply power to the main control module; the main control module is suitable for sending a control signal to a light string to turn on or turn off the light string or to switch a color; the protection module is suitable for identifying a magnitude of a current in the first power supply module, converting the current into a detection signal, and then sending the detection signal to the main control module; the main control module is suitable for receiving and judging the detection signal; and when the detection signal exceeds a preset value, the main control module is suitable for sending a control signal to turn off the light string.

Abstract: The present invention discloses the synthetic methods and the corresponding applications of a benzothiaselenazole-1-oxide compound and derivatives thereof, in which with sulfoximine and elemental selenium as starting materials, a series of benzothiaselenazole-1-oxide compounds has been synthesized through rhodium-catalyzed direct C—H functionalization reaction. Furthermore, with sulfoximine and elemental selenium as starting materials, a chiral benzothiaselenazole-1-oxide compound is synthesized through direct C—H functionalization reaction by virtue of a chiral phosphoric acid ligand.

Abstract: Authorization methods and devices are provided. An authorization method includes that: a first network element checks authorization information of a user, and provides data of the user and/or a data analysis result to a second network element when a check result is as follows: collection and/or analysis of the data of the user is allowed; and the data of the user and/or the data analysis result is allowed to be provided to the second network element.

Abstract: Provided are combination therapies of a CLDN 18.2 antagonist and a PD-1/PD-L1 axis inhibitor for subjects having expression of CLDN 18.2 and having low or no expression of PD-L1 in a disease tissue (e.g., tumor tissue) obtained from the subject.

Abstract: A nasal aspirator includes a housing assembly, a negative pressure assembly and a guide assembly. A negative pressure cavity and a treatment cavity are arranged in the housing assembly at intervals, the treatment cavity is sequentially divided into a first cavity chamber and a second cavity chamber by a partition plate, and the first cavity chamber is communicated with the second cavity chamber; the negative pressure assembly is arranged in the negative pressure cavity and is formed with a suction pipeline and a discharge pipeline which are communicated with a side wall surface of the housing assembly; the guide assembly comprises a first guide piece and a second guide piece, and the first guide piece is detachably connected with the side wall surface of the housing assembly; and the second guide piece is fixedly connected to the side wall surface of the housing assembly.

Abstract: A bathtub includes a bathtub body, a face plate, a tray and a charging assembly. A shower cavity is arranged inside the bathtub body; the face plate surrounds a cavity opening of the shower cavity and is bent and connected with the bathtub body, and a charging groove is concavely provided towards an extending direction away from the cavity opening in the face plate; the tray is arranged on one side of the charging groove and fixedly connected to the face plate, and a bearing cavity is formed in the tray; and the charging assembly is arranged in the charging groove and detachably connected with the face plate, and the charging assembly is at least partially exposed from a groove opening of the charging groove.

Abstract: A breast-pumping care accessory and a care method are disclosed. The accessory includes a first attaching element, configured to be attached to a breast of a living body when in operation; a second attaching element; a heating element, located between the first attaching element and the second attaching element; a controller, electrically connected to the heating element; and an energy supply element, configured to supply electric energy to the heating element and the controller. The controller is configured to perform a care controlling method including: obtaining a target breast-pumping care mode; obtaining a heating curve based on the target breast-pumping care mode from a curve library and taking the heating curve as a target curve; and controlling the heating element to generate heat based on the target curve. The target breast-pumping care mode includes any one of a pre-pumping care mode, an in-pumping care mode, and a post-pumping care mode.

Abstract: A breast pump is disclosed. The breast pump includes a body and a heating assembly. The body defines a channel. The heating assembly includes an attaching member and a charging device. The attaching member is electrically connected to the charging device. The attaching member is at least partially arranged in the channel. The charging device is connected to the body. The heating assembly is connected to the body. The attaching member is located on a side of the body that is capable of contacting with a breast and configured to contact with the breast. The heating assembly is further configured to generate heat through the charging device.

Abstract: The present application relates to the field of communications technologies, and provides a method for controlling a radio frequency front-end device and user equipment, where the user equipment includes a processor and the radio frequency front-end device, and the method includes: receiving, by the radio frequency front-end device, a switch control instruction from the processor, where the switch control instruction is an instruction sent by the processor to the radio frequency front-end device at a first moment; and performing, by the radio frequency front-end device, on-off switching in response to the switch control instruction.

Abstract: Disclosed is a wide-jaw-opening nail clipper, and the nail clipper includes: a first blade head portion formed at a first handle, and an upper blade formed at the first blade head portion, where an upper blade tip extends forward farther than an upper blade tail; a second blade head portion formed at a second handle, where the second blade head portion is provided with a butt-joint position, a lower blade is formed at the second blade head portion, a lower blade tip extends forward farther than a lower blade tail, and the upper blade tip and the lower blade tip both form a pointed cone shape; and the first blade head portion is rotatably connected to the second blade head portion, an elastic member is installed inside a mounting groove, and the first blade head portion and the second blade head portion together form a trimming blade head.

Abstract: This application provides a radio frequency control method and apparatus, and an electronic device. The electronic device includes a first power amplifier, a dual-cell battery module, and a voltage conversion chip. The dual-cell battery module is connected to the first power amplifier through the voltage conversion chip. The radio frequency control method includes: detecting a network standard according to which the electronic device operates; and when the network standard according to which the electronic device operates is a first network standard, adjusting a switching frequency of the voltage conversion chip to improve an isolation of the first power amplifier.

Abstract: The present application belongs to the technical field of proteolysis-targeting chimeras (PROTACs), and discloses a PROTAC molecule and a preparation method and use thereof. A ligand for a target protein in the PROTAC molecule of the present application is a pyridine carboxylic acid-1-oxide derivative. In cell and zebrafish experiments, the PROTAC molecule exhibits no toxic and side effects at a drug concentration allowing a desired effect. At a cellular level, an inhibition level of the PROTAC molecule for human tyrosinase (TYR) reaches less than or equal to 1 ?mol/L. The PROTAC molecule in the present application can significantly reduce the generation of melanin by degrading TYR, and has excellent solubility, safety, and efficacy and a low effective concentration.

Abstract: The present disclosure discloses a high-pressure white-red-green-blue (WRGB) string light, including a controller and a string light main body. The controller is connected with the string light main body; the string light main body is provided with a plurality of WRGB bulbs; the controller includes a first power supply module and a main control module; the first power supply module is adapted to be connected to a mains supply to supply power to the main control module; the WRGB bulbs include a second power supply module, an auxiliary control module and a lighting module; the second power supply module is adapted to be connected to the controller or the main supply to supply power to the auxiliary control module and the lighting module; and the main control module is adapted to send a control signal to the auxiliary control module.

Abstract: A bit index explicit replication (BIER) operations, administration, and maintenance (OAM) detection method includes a bit forwarding ingress router (BFIR) obtaining a detection request packet based on a first BIER OAM packet, and sending the detection request packet to at least one bit forwarding egress router BFER. The detection request packet includes a first packet and a first packet header. The first packet is a packet obtained by encapsulating the first BIER OAM packet. The first packet header includes a bit string, and the bit string indicates the at least one bit forwarding egress router BFER that is to be measured.

Abstract: The present invention provides a method for sorting lithium cells, which includes quick sorting and high-precision sorting. The method provided by the present invention can be used for quickly and accurately classifying cells based on self-discharge, and is applicable to large-scale self-discharge sorting due to low cost of adopted equipment. Through the quick sorting method and the high-precision sorting method in the present invention, cells with large self-discharge rates can be eliminated from a batch of cells, cells with similar self-discharge rates can be sorted into groups, and an application range is wider.

Abstract: In at least one illustrative embodiment, a system for wireless soil humidity sensing includes one or more wireless sensors. Each sensor includes a capacitor and an inductor, the capacitor having a dielectric material with a high relative dielectric permittivity that changes in response to changes in environmental humidity. The dielectric material may be a ceramic material such as a core-shell composite including barium titanate (BaTiO3) and silicon dioxide (SiO2). The capacitor may include two opposing sides, with a pair of electrodes positioned on one of the sides. An encapsulation layer such as epoxy may cover the side of the capacitor having the electrode. Sensors may be distributed throughout the soil in an area such as a farm field. The resonant frequency of one or more wireless sensors may be measured, and relative humidity of the soil may be determined based on the resonant frequency. Other embodiments are described and claimed.

Abstract: The present application belongs to the technical field of proteolysis-targeting chimeras (PROTACs), and discloses a PROTAC molecule and a preparation method and use thereof. A ligand for a target protein in the PROTAC molecule of the present application is a pyridine carboxylic acid-1-oxide derivative. In cell and zebrafish experiments, the PROTAC molecule exhibits no toxic and side effects at a drug concentration allowing a desired effect. At a cellular level, an inhibition level of the PROTAC molecule for human tyrosinase (TYR) reaches less than or equal to 1 ?mol/L. The PROTAC molecule in the present application can significantly reduce the generation of melanin by degrading TYR, and has excellent solubility, safety, and efficacy and a low effective concentration.